Literature DB >> 16873272

Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain.

Anja Duda1, Daniel Lüftenegger, Thomas Pietschmann, Dirk Lindemann.   

Abstract

The foamy virus (FV) glycoprotein precursor gp130(Env) undergoes a highly unusual biosynthesis, resulting in the generation of three particle-associated, mature subunits, leader peptide (LP), surface (SU), and transmembrane (TM). Little structural and functional information on the extracellular domains of FV Env is available. In this study, we characterized the prototype FV (PFV) Env receptor-binding domain (RBD) by flow cytometric analysis of recombinant PFV Env immunoadhesin binding to target cells. The extracellular domains of the C-terminal TM subunit as well as targeting of the recombinant immunoadhesins by the cognate LP to the secretory pathway were dispensable for target cell binding, suggesting that the PFV Env RBD is contained within the SU subunit. N- and C-terminal deletion analysis of the SU domain revealed a minimal continuous RBD spanning amino acids (aa) 225 to 555; however, internal deletions covering the region from aa 397 to 483, but not aa 262 to 300 or aa 342 to 396, were tolerated without significant influence on host cell binding. Analysis of individual cysteine point mutants in PFV SU revealed that only most of those located in the nonessential region from aa 397 to 483 retained residual binding activity. Interestingly, analysis of various N-glycosylation site mutants suggests an important role of carbohydrate chain attachment to N391, either for direct interaction with the receptor or for correct folding of the PFV Env RBD. Taken together, these results suggest that a bipartite sequence motif spanning aa 225 to 396 and aa 484 to 555 is essential for formation of the PFV Env RBD, with N-glycosylation site at position 391 playing a crucial role for host cell binding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873272      PMCID: PMC1563792          DOI: 10.1128/JVI.00460-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  The intact retroviral Env glycoprotein of human foamy virus is a trimer.

Authors:  T Wilk; F de Haas; A Wagner; T Rutten; S Fuller; R M Flügel; M Löchelt
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity.

Authors:  Anja Duda; Annett Stange; Daniel Lüftenegger; Nicole Stanke; Dana Westphal; Thomas Pietschmann; Scott W Eastman; Maxine L Linial; Axel Rethwilm; Dirk Lindemann
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence.

Authors:  I MACPHERSON; M STOKER
Journal:  Virology       Date:  1962-02       Impact factor: 3.616

4.  Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release.

Authors:  Nicole Stanke; Annett Stange; Daniel Lüftenegger; Hanswalter Zentgraf; Dirk Lindemann
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1.

Authors:  R A Davey; C A Hamson; J J Healey; J M Cunningham
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Characterization of the R572T point mutant of a putative cleavage site in human foamy virus Env.

Authors:  A Bansal; K L Shaw; B H Edwards; P A Goepfert; M J Mulligan
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins.

Authors:  D Lindemann; M Bock; M Schweizer; A Rethwilm
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Furin-mediated cleavage of the feline foamy virus Env leader protein.

Authors:  Verena Geiselhart; Patrizia Bastone; Tore Kempf; Martina Schnölzer; Martin Löchelt
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  Properties of human foamy virus relevant to its development as a vector for gene therapy.

Authors:  Claire L Hill; Paul D Bieniasz; Myra O McClure
Journal:  J Gen Virol       Date:  1999-08       Impact factor: 3.891

10.  Analysis and function of prototype foamy virus envelope N glycosylation.

Authors:  Daniel Lüftenegger; Marcus Picard-Maureau; Nicole Stanke; Axel Rethwilm; Dirk Lindemann
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

View more
  9 in total

Review 1.  Molecular biology of foamy viruses.

Authors:  Axel Rethwilm
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

2.  Cell Membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells.

Authors:  Md Nasimuzzaman; Derek A Persons
Journal:  Mol Ther       Date:  2012-03-20       Impact factor: 11.454

3.  Plasma antibodies from humans infected with zoonotic simian foamy virus do not inhibit cell-to-cell transmission of the virus despite binding to the surface of infected cells.

Authors:  Mathilde Couteaudier; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Antoine Gessain; Florence Buseyne
Journal:  PLoS Pathog       Date:  2022-05-23       Impact factor: 7.464

4.  Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells.

Authors:  Yue Si; Anna C Pulliam; Yvonne Linka; Samantha Ciccone; Cordula Leurs; Jin Yuan; Olaf Eckermann; Stefan Fruehauf; Sean Mooney; Helmut Hanenberg; D Wade Clapp
Journal:  Blood       Date:  2008-08-06       Impact factor: 22.113

5.  Cocirculation of Two env Molecular Variants, of Possible Recombinant Origin, in Gorilla and Chimpanzee Simian Foamy Virus Strains from Central Africa.

Authors:  Léa Richard; Réjane Rua; Edouard Betsem; Augustin Mouinga-Ondémé; Mirdad Kazanji; Eric Leroy; Richard Njouom; Florence Buseyne; Philippe V Afonso; Antoine Gessain
Journal:  J Virol       Date:  2015-10-07       Impact factor: 5.103

Review 6.  Foamy virus vectors for gene transfer.

Authors:  Grant D Trobridge
Journal:  Expert Opin Biol Ther       Date:  2009-11       Impact factor: 4.388

7.  Modular nature of simian foamy virus genomes and their evolutionary history.

Authors:  Pakorn Aiewsakun; Léa Richard; Antoine Gessain; Augustin Mouinga-Ondémé; Philippe Vicente Afonso; Aris Katzourakis
Journal:  Virus Evol       Date:  2019-10-16

Review 8.  Early events in foamy virus-host interaction and intracellular trafficking.

Authors:  Ursula Berka; Martin Volker Hamann; Dirk Lindemann
Journal:  Viruses       Date:  2013-04-08       Impact factor: 5.048

9.  Potent neutralizing antibodies in humans infected with zoonotic simian foamy viruses target conserved epitopes located in the dimorphic domain of the surface envelope protein.

Authors:  Caroline Lambert; Mathilde Couteaudier; Julie Gouzil; Léa Richard; Thomas Montange; Edouard Betsem; Réjane Rua; Joelle Tobaly-Tapiero; Dirk Lindemann; Richard Njouom; Augustin Mouinga-Ondémé; Antoine Gessain; Florence Buseyne
Journal:  PLoS Pathog       Date:  2018-10-08       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.